Using continuous quality improvement tools to improve pediatric immunization rates

E Carlin1, R Carlson, J Nordin

  • 1HealthPartners, Minneapolis, MN 55440-1309, USA.

The Joint Commission Journal on Quality Improvement
|April 1, 1996
PubMed

Insights

Continuous quality improvement (CQI) teams enhanced pediatric immunization rates by addressing missed opportunities and improving record-keeping. This initiative significantly boosted two-year-old immunization coverage from 53.5% to 86.5%.

Area of Science:

  • Public Health
  • Healthcare Quality Improvement
  • Pediatric Medicine

Background:

  • A continuous quality improvement (CQI) team was established in 1992 to address low pediatric immunization rates in Minnesota.
  • Key barriers identified included missed opportunities during clinic visits, incomplete records, and parental instructions for delayed follow-up.

Purpose of the Study:

  • To improve two-year-old immunization rates within a network of medical clinics.
  • To identify and mitigate factors contributing to incomplete childhood immunizations.

Main Methods:

  • The CQI team analyzed the existing immunization process, collected data on immunization status, and identified root causes for delays.
  • Interventions included developing provider algorithms for catch-up immunizations, streamlining immunization record-keeping, and piloting automated vaccine administration records.

Main Results:

  • Pediatric immunization rates increased from a baseline average of 53.5% to 86.5% over the most recent four quarters.
  • The implemented strategies effectively addressed missed opportunities and improved overall vaccination coverage.

Conclusions:

  • Empowering frontline healthcare teams to address quality issues is crucial for driving improvements.
  • Collaborative, data-driven approaches can significantly enhance pediatric immunization rates and public health outcomes.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Health Information Technology and Healthcare Information System01:30

Health Information Technology and Healthcare Information System

Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...